Additionally, the hyperactivity of the DNA methyltransferase enzymes, or the over-expression of DNMT3B, has been further reported in BLBCs and TNBCs, where the hypermethylation events were more frequent than in other breast cancer subtypes [54]. Here, DNMT3B is linked to breast cancer.